An interpretable multi-scale convolutional attention residual neural network for glioma grading with Raman...

Since the malignancy of gliomas varies with their grade, classifying gliomas of different grades can assist doctors in developing personalized surgical plans during surgery, thereby improving the prognosis. Raman spectroscopy is an optical method for real-time glioma diagnosis. However, high-grade glioma (HGG, WHO grades III and IV), low-grade glioma (LGG, WHO grades I and II) and normal tissue have similar biochemical components, leading to similar spectral characteristics. This similarity reduces classification accuracy when using traditional machine learning methods. In contrast, deep learning offers enhanced feature extraction capabilities without the need for extensive feature engineering. Nevertheless, the diversity in the scale of spectral features presents challenges in designing a neural network that effectively adapts to these characteristics. To address these issues, this paper proposes a Multi-Scale Convolutional Attention Residual Network (M-SCA ResNet), which incorporates multi-scale channel and spatial attention mechanisms along with residual structures to improve the model's feature extraction capabilities. The algorithm presented in this study, was employed to classify HGG, LGG, and healthy tissue and was compared with conventional machine learning and neural networks. The results indicate that the M-SCA ResNet achieved an identification accuracy exceeding 85% for all three tissue types, along with the highest weighted F₁-score. Furthermore, to enhance the interpretability of deep learning models, Gradient-weighted Class Activation Mapping (Grad-CAM) was utilized to extract and visualize key Raman shifts that significantly contribute to classification. Most of the extracted Raman shifts correspond to characteristic peaks of brain tissue which have been demonstrated to be effective in distinguishing between glioma of different grades and normal tissue in previous studies. This finding proves the strong correlation between the feature extraction capabilities of the M-SCA ResNet and the biomolecular characteristics of various tissues. The experiments conducted in this study validate the feasibility of using the M-SCA ResNet for glioma grading and provide valuable support for formulating subsequent surgical and treatment plans, indicating its promising application in in vivo and in situ spectral diagnosis of glioma grading.